RecruitingPhase 2NCT06619561
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Principal Investigator
- Clinical TeamDeciphera Pharmaceuticals, LLC
- Intervention
- Vimseltinib(drug)
- Enrollment
- 48 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2029
Study locations (26)
- City of Hope National Medical Center, Duarte, California, United States
- Ronald Regan UCLA Medical Center, Los Angeles, California, United States
- University of California Irvine Health, Orange, California, United States
- AdventHealth Orlando, Orlando, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Emory University Winship Cancer Institute, Atlanta, Georgia, United States
- University of Illinois Medical Center - Hematology & Oncology, Chicago, Illinois, United States
- University of Kansas Cancer Center-Westwood, Westwood, Kansas, United States
- University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Henry Ford Cancer Institute, Detroit, Michigan, United States
- Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Duke University Hospital, Durham, North Carolina, United States
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06619561 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo